Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.01
VTR's Cash to Debt is ranked lower than
51% of the 612 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.05 vs. VTR: 0.01 )
VTR' s 10-Year Cash to Debt Range
Min: 0   Max: No Debt
Current: 0.01

Equity to Asset 0.44
VTR's Equity to Asset is ranked higher than
63% of the 639 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.49 vs. VTR: 0.44 )
VTR' s 10-Year Equity to Asset Range
Min: -0.15   Max: 0.54
Current: 0.44

-0.15
0.54
Interest Coverage 1.56
VTR's Interest Coverage is ranked higher than
63% of the 552 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 2.43 vs. VTR: 1.56 )
VTR' s 10-Year Interest Coverage Range
Min: 0.14   Max: 3.18
Current: 1.56

0.14
3.18
F-Score: 7
Z-Score: 1.20
M-Score: -2.45
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 19.17
VTR's Operating margin (%) is ranked higher than
56% of the 648 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 42.30 vs. VTR: 19.17 )
VTR' s 10-Year Operating margin (%) Range
Min: 0.36   Max: 45.84
Current: 19.17

0.36
45.84
Net-margin (%) 16.57
VTR's Net-margin (%) is ranked higher than
60% of the 649 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 34.15 vs. VTR: 16.57 )
VTR' s 10-Year Net-margin (%) Range
Min: -30.87   Max: 85.67
Current: 16.57

-30.87
85.67
ROE (%) 5.52
VTR's ROE (%) is ranked higher than
67% of the 658 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 6.73 vs. VTR: 5.52 )
VTR' s 10-Year ROE (%) Range
Min: 3.97   Max: 12109.6
Current: 5.52

3.97
12109.6
ROA (%) 2.48
VTR's ROA (%) is ranked higher than
68% of the 659 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 3.07 vs. VTR: 2.48 )
VTR' s 10-Year ROA (%) Range
Min: -6.38   Max: 19.05
Current: 2.48

-6.38
19.05
ROC (Joel Greenblatt) (%) 3.15
VTR's ROC (Joel Greenblatt) (%) is ranked higher than
59% of the 584 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 6.00 vs. VTR: 3.15 )
VTR' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: 2.36   Max: 24.96
Current: 3.15

2.36
24.96
Revenue Growth (%) 14.50
VTR's Revenue Growth (%) is ranked higher than
95% of the 540 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.00 vs. VTR: 14.50 )
VTR' s 10-Year Revenue Growth (%) Range
Min: -59.1   Max: 30.6
Current: 14.5

-59.1
30.6
EBITDA Growth (%) 11.70
VTR's EBITDA Growth (%) is ranked higher than
85% of the 499 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 4.00 vs. VTR: 11.70 )
VTR' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 36.2
Current: 11.7

0
36.2
EPS Growth (%) 7.10
VTR's EPS Growth (%) is ranked higher than
77% of the 405 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.20 vs. VTR: 7.10 )
VTR' s 10-Year EPS Growth (%) Range
Min: -6.2   Max: 36.1
Current: 7.1

-6.2
36.1
» VTR's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q4 2013

VTR Guru Trades in Q4 2013

Ray Dalio 356,227 sh (+281.53%)
Chris Davis 476,589 sh (+3.75%)
Jeremy Grantham 73,484 sh (+1.17%)
Steven Romick -61,800 sh (unchged)
Pioneer Investments 112,309 sh (-6.03%)
Manning & Napier Advisors, Inc 145,561 sh (-18.54%)
Steven Cohen 5,928 sh (-90.94%)
» More
Q1 2014

VTR Guru Trades in Q1 2014

Steven Cohen 11,909 sh (+100.89%)
Chris Davis 506,837 sh (+6.35%)
Pioneer Investments 113,784 sh (+1.31%)
Steven Romick -61,800 sh (unchged)
Manning & Napier Advisors, Inc 145,253 sh (-0.21%)
Jeremy Grantham 63,600 sh (-13.45%)
Ray Dalio 289,346 sh (-18.77%)
» More
Q2 2014

VTR Guru Trades in Q2 2014

Jim Simons 336,754 sh (New)
Steven Romick -61,800 sh (unchged)
Pioneer Investments 111,145 sh (-2.32%)
Manning & Napier Advisors, Inc 138,039 sh (-4.97%)
Jeremy Grantham 59,400 sh (-6.6%)
Ray Dalio 263,384 sh (-8.97%)
Chris Davis 261,166 sh (-48.47%)
» More
Q3 2014

VTR Guru Trades in Q3 2014

Steven Romick -61,800 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with VTR

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

GuruDate Trades Impact to Portfolio Price Range * (?) Current Price Change from Average Current Shares
Chris Davis 2014-06-30 Reduce -48.47%0.04%$61.29 - $68.4 $ 66.973%261166
Ray Dalio 2013-12-31 Add 281.53%0.12%$55.26 - $67.33 $ 66.9710%356227
Ken Heebner 2013-09-30 Sold Out 1.2%$58.86 - $72.16 $ 66.973%0
Ray Dalio 2013-09-30 Add 595.32%0.04%$58.86 - $72.16 $ 66.973%93367
Ken Heebner 2013-06-30 New Buy1.2%$64.38 - $82.93 $ 66.97-11%630000
Chris Davis 2013-06-30 Reduce -38%0.04%$64.38 - $82.93 $ 66.97-11%383287
Ray Dalio 2013-06-30 New Buy0.01%$64.38 - $82.93 $ 66.97-11%13428
John Keeley 2013-06-30 Sold Out $64.38 - $82.93 $ 66.97-11%0
Chris Davis 2013-03-31 Reduce -32.21%0.05%$64.68 - $73.2 $ 66.97-2%618229
John Keeley 2012-09-30 New Buy$61.94 - $67.26 $ 66.974%3260
Ray Dalio 2012-06-30 Sold Out 0.07%$54.67 - $62.62 $ 66.9715%0
Ray Dalio 2012-03-31 Add 358.38%0.06%$53.68 - $58.98 $ 66.9726%79428
Chris Davis 2012-03-31 Reduce -26.8%0.05%$53.68 - $58.98 $ 66.9726%1061820
Ray Dalio 2011-12-31 New Buy0.02%$47.7 - $56.04 $ 66.9728%17328
Chris Davis 2011-09-30 Add 67.59%0.07%$43.96 - $55.5 $ 66.9729%1625646
Premium More recent guru trades are included for Premium Members only!!
Premium More recent guru trades are included for USA Subscribe Members only!!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Top Ranked Articles about Ventas Inc

GuruFocus Reports Top Dividend Growers of the Week
During the past week, GuruFocus recognized four companies as dividend growers. In order to be qualified for this list, the company had to: Read more...
GuruFocus Reports Seven Dividend Growers of the Week
During the past week, GuruFocus recognized seven companies as dividend growers. In order to be qualified for this list, the company had to: Read more...

Ratios

vs
industry
vs
history
P/E(ttm) 40.70
VTR's P/E(ttm) is ranked higher than
59% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 24.80 vs. VTR: 40.70 )
VTR' s 10-Year P/E(ttm) Range
Min: 9.88   Max: 62.82
Current: 40.7

9.88
62.82
P/B 2.28
VTR's P/B is ranked lower than
67% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.27 vs. VTR: 2.28 )
VTR' s 10-Year P/B Range
Min: 1.27   Max: 38.07
Current: 2.28

1.27
38.07
P/S 6.76
VTR's P/S is ranked higher than
64% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 7.70 vs. VTR: 6.76 )
VTR' s 10-Year P/S Range
Min: 3.01   Max: 11.78
Current: 6.76

3.01
11.78
EV-to-EBIT 52.10
VTR's EV-to-EBIT is ranked higher than
60% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 32.85 vs. VTR: 52.10 )
VTR' s 10-Year EV-to-EBIT Range
Min: 22.2   Max: 113.9
Current: 52.1

22.2
113.9
PEG 4.72
VTR's PEG is ranked higher than
87% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 9999.00 vs. VTR: 4.72 )
VTR' s 10-Year PEG Range
Min: 0.35   Max: 400.53
Current: 4.72

0.35
400.53
Shiller P/E 40.66
VTR's Shiller P/E is ranked higher than
73% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 9999.00 vs. VTR: 40.66 )
VTR' s 10-Year Shiller P/E Range
Min: 11.18   Max: 46.67
Current: 40.66

11.18
46.67
Current Ratio 0.29
VTR's Current Ratio is ranked higher than
53% of the 587 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.79 vs. VTR: 0.29 )
VTR' s 10-Year Current Ratio Range
Min: 0.1   Max: 1.18
Current: 0.29

0.1
1.18
Quick Ratio 0.29
VTR's Quick Ratio is ranked higher than
54% of the 587 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 0.78 vs. VTR: 0.29 )
VTR' s 10-Year Quick Ratio Range
Min: 0.1   Max: 1.18
Current: 0.29

0.1
1.18

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 4.33
VTR's Dividend Yield is ranked higher than
50% of the 640 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 4.30 vs. VTR: 4.33 )
VTR' s 10-Year Dividend Yield Range
Min: 3.1   Max: 10.06
Current: 4.33

3.1
10.06
Dividend Payout 1.76
VTR's Dividend Payout is ranked higher than
59% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.27 vs. VTR: 1.76 )
VTR' s 10-Year Dividend Payout Range
Min: 0.28   Max: 6.37
Current: 1.76

0.28
6.37
Dividend growth (3y) 8.50
VTR's Dividend growth (3y) is ranked higher than
77% of the 419 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 6.20 vs. VTR: 8.50 )
VTR' s 10-Year Dividend growth (3y) Range
Min: 0   Max: 34.6
Current: 8.5

0
34.6
Yield on cost (5-Year) 6.17
VTR's Yield on cost (5-Year) is ranked higher than
64% of the 641 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 4.82 vs. VTR: 6.17 )
VTR' s 10-Year Yield on cost (5-Year) Range
Min: 4.45   Max: 14.44
Current: 6.17

4.45
14.44
Share Buyback Rate -23.20
VTR's Share Buyback Rate is ranked higher than
54% of the 522 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: -7.00 vs. VTR: -23.20 )
VTR' s 10-Year Share Buyback Rate Range
Min: 1.9   Max: -24.5
Current: -23.2

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 2.41
VTR's Price/Tangible Book is ranked lower than
62% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.30 vs. VTR: 2.41 )
VTR' s 10-Year Price/Tangible Book Range
Min: 1.5   Max: 59.72
Current: 2.41

1.5
59.72
Price/DCF (Projected) 2.54
VTR's Price/DCF (Projected) is ranked higher than
71% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 7.40 vs. VTR: 2.54 )
VTR' s 10-Year Price/DCF (Projected) Range
Min: 2.09   Max: 429.75
Current: 2.54

2.09
429.75
Price/Median PS Value 0.87
VTR's Price/Median PS Value is ranked higher than
89% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.20 vs. VTR: 0.87 )
VTR' s 10-Year Price/Median PS Value Range
Min: 0.12   Max: 1.44
Current: 0.87

0.12
1.44
Price/Peter Lynch Fair Value 4.36
VTR's Price/Peter Lynch Fair Value is ranked higher than
85% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 9999.00 vs. VTR: 4.36 )
VTR' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.67   Max: 7.89
Current: 4.36

0.67
7.89
Price/Graham Number 2.09
VTR's Price/Graham Number is ranked higher than
50% of the 698 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.30 vs. VTR: 2.09 )
VTR' s 10-Year Price/Graham Number Range
Min: 1.05   Max: 5.05
Current: 2.09

1.05
5.05
Earnings Yield (Greenblatt) 1.90
VTR's Earnings Yield (Greenblatt) is ranked higher than
53% of the 598 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 3.70 vs. VTR: 1.90 )
VTR' s 10-Year Earnings Yield (Greenblatt) Range
Min: 0.9   Max: 4.5
Current: 1.9

0.9
4.5
Forward Rate of Return (Yacktman) 10.35
VTR's Forward Rate of Return (Yacktman) is ranked higher than
87% of the 526 Companies
in the Global REIT - Healthcare Facilities industry.

( Industry Median: 1.95 vs. VTR: 10.35 )
VTR' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -7.3   Max: 52.7
Current: 10.35

-7.3
52.7

Business Description

Industry: REITs » REIT - Healthcare Facilities
Compare:HTA, LTC, OHI, HCP, HR » details
Traded in other countries:VEN.Germany
Ventas Inc is a real estate investment trust with a portfolio of seniors housing and healthcare properties in the United States and Canada. The Company currently operates through three reportable business segments: triple-net leased properties, senior living operations and MOB operations. Triple-net leased properties segment consists of acquiring and owning seniors housing and healthcare properties in the United States and leasing those properties to healthcare operating companies under 'triple-net' or 'absolute-net' leases that require the tenants to pay all property-related expenses. Senior living operations segment primarily consists of investments in seniors housing communities located in the United States and Canada for which the Company engages independent third parties, such as Atria and Sunrise, to manage the operations. MOB operations segment primarily consists of acquiring, owning, developing, leasing and managing MOBs. As of December 31, 2011, the Company leased 929 properties (excluding MOBs) to healthcare operating companies under 'triple-net' or 'absolute-net' leases. The Company competes in the acquisition, leasing and financing of seniors housing and healthcare properties with publicly traded, private and non-listed healthcare REITs, real estate partnerships, healthcare providers, healthcare lenders and other investors, including without limitation developers, banks, insurance companies, pension funds, government sponsored entities and private equity firms. As an owner of real property, the Company is subject to various federal, state and local laws and regulations regarding environmental, health and safety matters. These laws and regulations address, among other things, asbestos, polychlorinated biphenyls, fuel oil management, wastewater discharges, air emissions, radioactive materials, medical wastes, and hazardous wastes, and in certain cases, the costs of complying with these laws and regulations and the penalties for non-compliance can be substantial.
» More Articles for VTR

Headlines

Articles On GuruFocus.com
Absolute and Relative Valuation Models Indicate a Sell Recommendation for Ventas Oct 20 2014 
GuruFocus Reports Top Dividend Growers of the Week Sep 10 2014 
GuruFocus Reports Top Five Dividend Growers of the Week May 20 2014 
GuruFocus Reports Seven Dividend Growers of the Week Feb 19 2014 
Sector Watch: Gurus Active on REITs at 52-Week Low Dec 26 2013 
GuruFocus Reports Weekly Top Dividend Growers Dec 16 2013 
8 Dividend Stocks Building Future Yield Dec 16 2013 
Weekly CEO Sells Highlight: Jack in the Box, Guidewire Software, Williams-Sonoma, and Ventas Mar 31 2013 
52-Week Highs Feb 26 2013 
good industry Feb 06 2013 

More From Our Partners
All-Star REITs To Boost The Dividend Power Of Any Portfolio, Part 1 Oct 24 2014 - SEEKINGALPHA

More From Other Websites
Ventas (VTR) Earnings Report: Q3 2014 Conference Call Transcript Oct 24 2014
Ventas Beats Q3 FFO on Revenue Growth, Ups 2014 Outlook Oct 24 2014
Ventas Inc Earnings Call scheduled for 10:00 am ET today Oct 24 2014
VENTAS INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial Statements... Oct 24 2014
Ventas reports 3Q results Oct 24 2014
Ventas reports 3Q results Oct 24 2014
7:33 am Ventas beats by $0.02, beats on revs; raises FY14 FFO guidance above consensus Oct 24 2014
Ventas Reports Eight Percent Increase in Third Quarter to Record Normalized FFO of $1.12 Per Diluted... Oct 24 2014
Q3 2014 Ventas Inc Earnings Release - Before Market Open Oct 24 2014
Can Ventas (VTR) Surprise on Solid Sector Scenario? Oct 22 2014
Absolute and Relative Valuation Models Indicate a Sell Recommendation for Ventas Oct 20 2014
Ventas CEO, Debra A. Cafaro, Recognized among Harvard Business Review’s “The Best-Performing... Oct 16 2014
Ventas CEO, Debra A. Cafaro, Recognized among Harvard Business Review’s “The Best-Performing... Oct 16 2014
Ventas upgraded by Stifel Oct 10 2014
US STOCKS-Wall Street sells off on growth concerns; volatility picks up Oct 09 2014
US STOCKS-Global growth concerns trigger Wall St selloff Oct 09 2014
UDR Capitalizing on Improving U.S. Market Fundamentals Oct 03 2014
Reasonable Leverage, Growth Prospects, Moats, and Valuation Guide Our REIT Picks Oct 03 2014
Ventas Announces Third Quarter 2014 Earnings Release Date and Conference Call Oct 01 2014
The Zacks Analyst Blog Highlights: ICICI Bank, HDFC Bank, Tata Motors, Infosys and Ventas Sep 30 2014

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK